223 related articles for article (PubMed ID: 9918849)
1. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome.
Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G
Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849
[TBL] [Abstract][Full Text] [Related]
2. Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome.
Sanij E; Hatzistavrou T; Hertzog P; Kola I; Wolvetang EJ
Biochem Biophys Res Commun; 2001 Oct; 287(4):1003-8. PubMed ID: 11573964
[TBL] [Abstract][Full Text] [Related]
3. Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.
Greber-Platzer S; Schatzmann-Turhani D; Cairns N; Balcz B; Lubec G
J Neural Transm Suppl; 1999; 57():269-81. PubMed ID: 10666682
[TBL] [Abstract][Full Text] [Related]
4. Beta-amyloid precursor protein, ETS-2 and collagen alpha 1 (VI) chain precursor, encoded on chromosome 21, are not overexpressed in fetal Down syndrome: further evidence against gene dosage effect.
Engidawork E; Baiic N; Fountoulakis M; Dierssen M; Greber-Platzer S; Lubec G
J Neural Transm Suppl; 2001; (61):335-46. PubMed ID: 11771756
[TBL] [Abstract][Full Text] [Related]
5. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
6. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
7. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
8. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III).
Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G
Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744
[TBL] [Abstract][Full Text] [Related]
9. Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.
Kazuki Y; Kimura M; Nishigaki R; Kai Y; Abe S; Okita C; Shirayoshi Y; Schulz TC; Tomizuka K; Hanaoka K; Inoue T; Oshimura M
Biochem Biophys Res Commun; 2004 Apr; 317(2):491-9. PubMed ID: 15063784
[TBL] [Abstract][Full Text] [Related]
10. In vivo modulation of ETS genes induced by electromagnetic fields.
Mucci N; Ianni A; Ursini CL; Arzani D; Bhat NK; Navarra P; Romano-Spica V
In Vivo; 2001; 15(6):489-94. PubMed ID: 11887334
[TBL] [Abstract][Full Text] [Related]
11. Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos.
Lie-Venema H; Gittenberger-de Groot AC; van Empel LJ; Boot MJ; Kerkdijk H; de Kant E; DeRuiter MC
Circ Res; 2003 Apr; 92(7):749-56. PubMed ID: 12637368
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
13. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice.
Sumarsono SH; Wilson TJ; Tymms MJ; Venter DJ; Corrick CM; Kola R; Lahoud MH; Papas TS; Seth A; Kola I
Nature; 1996 Feb; 379(6565):534-7. PubMed ID: 8596630
[TBL] [Abstract][Full Text] [Related]
14. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome.
Pritchard MA; Kola I
J Neural Transm Suppl; 1999; 57():293-303. PubMed ID: 10666684
[TBL] [Abstract][Full Text] [Related]
15. Ets transcription factors and targets in osteogenesis.
Raouf A; Seth A
Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
[TBL] [Abstract][Full Text] [Related]
16. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
17. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
[TBL] [Abstract][Full Text] [Related]
18. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
19. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
20. Linkage of elevated ets-2 expression to hepatocarcinogenesis.
Ito Y; Miyoshi E; Takeda T; Nagano H; Sakon M; Noda K; Tsujimoto M; Monden M; Matsuura N
Anticancer Res; 2002; 22(4):2385-9. PubMed ID: 12174931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
